Search Results

Results for "-(Q威信/756030088）-美国维拉诺瓦大学毕业证|制作假西佐治亚大学毕业证|新加坡第一媒体设计学院毕业证|idc=husR/feed/cptaadmin@c-path.org"

June 10, 2024

Advocate Sarah Dolan Brings a Patient Voice to FDA Committee Reviewing New Alzheimer’s Drug Donanemab

On Monday, June 10, the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory...

June 20, 2024

Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease

C-Path's Rare and Orphan Disease Programs is excited to have Dr. Anthony Bleyer present it's June webinar...

June 5, 2024

eCOA Masterclass #1: The Road to Best Practice Consensus: Electronic Migration and Implementation of PRO Measures

Join the co-authors of the published article in Value in Health for a deep dive into existing and current best practices for the..

May 30, 2024

C-Path Supports Gleason, ALS Community at IgNight ALS

The C-Path team was incredibly humbled to be a part of IgNight ALS recently in Washington, D.C., honoring Steve Gleason and celebr

May 28, 2024

Accelerating healthcare innovation: the role of Artificial intelligence and digital health technologies in critical path institute’s public-private partnerships

Artificial Intelligence (AI) and Digital Health Technologies (DHTs) are radically transforming drug development. The FDA and EMA..

May 23, 2024

C-Path’s RDCA-DAP Webinar, “The Use and Development of DHTs with Patient Advocacy Groups” a Hit, with Keynote, Patient Advocacy Panel, and Engaged QAs

Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), part of C-Path's Rare...

May 23, 2024

Webinar: The Use and Development of DHTs with Patient Advocacy Groups

Join C-Path and Dr. Laurent Servais for an overview of Actimyo and relevant learnings...

May 22, 2024

C-Path Roundtable: Help4HD Unites to Discuss Advancements in Huntington’s Disease Treatments

"My husband passed away with no therapies, no treatments that worked for him, and it took away his quality of life...

May 15, 2024

TRxA BioBRIDGe Awards: Supporting the Next Generation of Protein-Based Therapeutics

TRxA is proud to announce the 2024 global Request for Proposals for its Biologics-focused Bridging Research...

May 15, 2024

NEW FUNDING OPPORTUNITY! C-Path’s TRxA Announces its First Biologics-focused RFP for Academic Investigators

C-Path Translational Therapeutics Accelerator (TRxA) today announced its inaugural biologics-focused Request for Proposals (RFP)..

Previous2324 25...139 Next